Scientific Studies: Diagnostic Markers for MCS
MCS
Researchers at the Department of Public Health Sciences at the
Physicians treating MCS often observe low mineral levels or changes in intra-erythrocytic minerals (IEMs) that
may affect proper detoxification of xenobiotics (foreign chemical substances
found in the body).
The participants tested were validated by current criteria for MCS diagnosis
and compared to a control group that did not meet the current criteria. All
participants diagnosed with MCS had lower levels of copper, chromium,
magnesium, molybdenum, sulphur and zinc, than those
without MCS.
Past studies have also found reduced mineral levels in MCS subjects.
However, because the difference is not statistically significant and no
dose-response relationships have been found, intra-erythrocytic
minerals do not seem to be useful diagnostic markers for MCS.
Many questions still remain. Could a slight reduction of these minerals
affect detoxification of xenobiotics? Or, could improper detoxification
of xenobiotics reduce these mineral levels?
In either case, would supplementation with these minerals aid in symptoms
reduction or correction of the condition? Indeed both Martin Pall and
Grace Ziem recommend similar supplement protocols to reduce the symptoms of
MCS. While both protocols have been said to assist with symptom reduction
and increased quality of life, neither has been proven effective enough to cure
MCS.
Lower mineral levels do appear to be a piece of the MCS puzzle.
Researchers are still searching for the remaining pieces that will serve as
confirmed biomarkers for the diagnosis of MCS. In the meantime, intra-erythrocytic mineral testing and supplementation may be in
order.
Reference
Baines CJ, McKeown-Eyssen GE, Riley N, Marshall L, Jazmaji V.
Copyrighted © 2008 MCS